🏛️ Verified NIH Record • Updated 2026-04-16
A Phase 2 in Adult Subjects With Hereditary Angioedema (NCT06846398)
A Phase 2, Open-label, Multicenter Study to Assess the Efficacy and Safety of BW-20805 in Adult Subjects With Hereditary Angioedema
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd.
🩺 Plain-English Summary (8th-Grade Level)
A Phase 2 in Adult Subjects with Hereditary Angioedema
Who can join: Review the eligibility criteria below.
Location: Institute for Asthma and Allergy - Wheaton — Silver Spring, Maryland
Age range: 18 Years to 70 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (18 Sites)
- Institute for Asthma and Allergy - Wheaton — Silver Spring, Maryland
- Washington University School of Medicine — St Louis, Missouri
- Duke University Medicine Center — Durham, North Carolina
- Penn State Milton S. Hershey MC - Penn State — Hershey, Pennsylvania
- Inova Clinical Trials and Research Center — Falls Church, Virginia
- Peking Union Medical College Hospital — Beijing, Beijing Municipality
- The First Hospital of Lanzhou University — Lanzhou, Gansu
- Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology — Wuhan, Hubei
- Yantai Yuhuangding Hospital — Yantai, Shandong
- West China Hospital, Sichuan University — Chengdu, Sichaun
- First Affiliated Hospital of Kunming Medical University — Kunming, Yunnan
- Universitätsmedizin der Johannes Gutenberg — Mainz, Rhineland-Palatinate
- Charité - Universitätsmedizin Berlin — Berlin, State of Berlin
- Azienda Ospedaliero Universitaria Policlinico G. Rodolico San Marco - Ospedale San Marco — Catania, Catania
- Azienda Ospedaliero-Universitaria Careggi — Florence, Florence
- Azienda Ospedale - Universita di Padova — Padova, PD
- SP ZOZ Szpital Uniwersytecki w Krakowie — Krakow, Lesser Poland Voivodeship
- Hospital Universitario Virgen del Rocío — Seville, Sevilla
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Hereditary Angioedema (HAE)
- A Study of Navenibart in Participants With Hereditary Angioedema — Birmingham, Alabama
- Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE — Little Rock, Arkansas
- Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE — Birmingham, Alabama
- Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients — Wheaton, Maryland
- Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE) — Litchfield Park, Arizona
Explore by condition: All Hereditary Angioedema (HAE) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.